8
Participants
Start Date
June 30, 2005
Primary Completion Date
July 31, 2006
Study Completion Date
September 30, 2006
argatroban
beginning dose: 0.7microgram/kg/H
The University of Tokyo Hospital, Tokyo
National Hospital Organization Tokyo Medical Center, Tokyo
Keio University Hospital, Tokyo
Sakakibara Memorial Hospital, Fuchū
Tokai University Hospital, Isehara
National Hospital Organization Nagoya Medical Center, Nagoya
Nagoya University Hospital, Nagoya
Nagoya Daini Red Cross Hospital, Nagoya
Mie University Hospital, Tsu
National Cardiovascular Center, Suita
Kyoto Second Red Cross Hospital, Kyoto
Kyoto University Hospital, Kyoto
Kobe University Hospital, Kobe
Kobe City General Hospital, Kobe
National Hospital Organization Iwakuni Clinical Center, Iwakuni
Yamaguchi University Hospital, Ube
Kurume University Hospital, Kurume
National Hospital Organization Hakodate National Hospital, Hakodate
National Hospital Organization Hokkaido Cancer Center, Sapporo
Iwate Medical University Hospital, Morioka
Collaborators (1)
Mitsubishi Tanabe Pharma Corporation
INDUSTRY
Ministry of Health, Labour and Welfare, Japan
OTHER_GOV